Testing targeted demethylation to overcome resistance to epidermal growth factor receptor (EGFR) blocking agents in wild-type (wt) KRAS metastatic colorectal cancer patients (mCRC).
Ignacio Garrido-Laguna
No relevant relationships to disclose
Kimberly McGregor
No relevant relationships to disclose
Mark Wade
No relevant relationships to disclose
John R. Weis
No relevant relationships to disclose
Laura Burr
No relevant relationships to disclose
Raffaella Soldi
No relevant relationships to disclose
Cynthia Davidson
No relevant relationships to disclose
Loni Jakubowski
No relevant relationships to disclose
Glen Morrell
No relevant relationships to disclose
Jeffrey Olpin
No relevant relationships to disclose
David Jones
No relevant relationships to disclose
Sunil Sharma
No relevant relationships to disclose